LS Investment Advisors LLC decreased its stake in shares of Xylem Inc. (NYSE:XYL) by 5.4% during the second quarter, according to its most recent disclosure with the SEC. The firm owned 32,055 shares of the company’s stock after selling 1,844 shares during the period. LS Investment Advisors LLC’s holdings in Xylem were worth $1,431,000 as of its most recent filing with the SEC.
Other hedge funds have also made changes to their positions in the company. Renaissance Technologies LLC acquired a new stake in shares of Xylem during the first quarter valued at approximately $35,673,000. Legal & General Group Plc boosted its stake in shares of Xylem by 1.8% in the first quarter. Legal & General Group Plc now owns 767,829 shares of the company’s stock valued at $31,403,000 after buying an additional 13,271 shares during the last quarter. Meeder Asset Management Inc. boosted its stake in shares of Xylem by 45.9% in the first quarter. Meeder Asset Management Inc. now owns 25,240 shares of the company’s stock valued at $1,032,000 after buying an additional 7,938 shares during the last quarter. Geode Capital Management LLC boosted its stake in shares of Xylem by 1.1% in the first quarter. Geode Capital Management LLC now owns 1,484,650 shares of the company’s stock valued at $60,604,000 after buying an additional 15,589 shares during the last quarter. Finally, Adage Capital Partners GP L.L.C. boosted its stake in shares of Xylem by 362.8% in the first quarter. Adage Capital Partners GP L.L.C. now owns 1,240,920 shares of the company’s stock valued at $50,754,000 after buying an additional 972,803 shares during the last quarter. Institutional investors and hedge funds own 84.70% of the company’s stock.
Xylem Inc. (NYSE:XYL) traded down 0.75% during midday trading on Monday, hitting $50.38. 1,039,452 shares of the stock were exchanged. Xylem Inc. has a one year low of $31.67 and a one year high of $53.25. The firm has a 50-day moving average price of $51.04 and a 200-day moving average price of $46.29. The stock has a market cap of $9.03 billion, a P/E ratio of 26.90 and a beta of 1.14.
Xylem (NYSE:XYL) last posted its quarterly earnings data on Tuesday, August 2nd. The company reported $0.48 earnings per share for the quarter, beating analysts’ consensus estimates of $0.47 by $0.01. Xylem had a net margin of 9.22% and a return on equity of 16.41%. The firm had revenue of $932 million for the quarter, compared to analyst estimates of $927.69 million. During the same period last year, the firm posted $0.43 EPS. Xylem’s quarterly revenue was up 1.3% on a year-over-year basis. On average, equities research analysts anticipate that Xylem Inc. will post $2.04 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, September 21st. Investors of record on Wednesday, August 31st were given a $0.1549 dividend. The ex-dividend date was Monday, August 29th. This represents a $0.62 dividend on an annualized basis and a yield of 1.23%. Xylem’s dividend payout ratio (DPR) is 33.16%.
Several equities analysts recently issued reports on XYL shares. RBC Capital Markets set a $51.00 target price on shares of Xylem and gave the company a “buy” rating in a research note on Tuesday, August 16th. Barclays PLC boosted their target price on shares of Xylem from $39.00 to $45.00 and gave the company an “equal weight” rating in a research note on Monday, July 18th. Canaccord Genuity reiterated a “hold” rating and issued a $50.00 target price (up from $45.00) on shares of Xylem in a research note on Tuesday, August 16th. Zacks Investment Research cut shares of Xylem from a “buy” rating to a “hold” rating in a research note on Friday, July 15th. Finally, Royal Bank Of Canada boosted their target price on shares of Xylem from $47.00 to $51.00 and gave the company an “outperform” rating in a research note on Tuesday, August 16th. Nine equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. Xylem presently has an average rating of “Hold” and an average target price of $45.00.
In other Xylem news, insider Colin R. Sabol sold 27,473 shares of the firm’s stock in a transaction on Thursday, September 8th. The stock was sold at an average price of $50.91, for a total value of $1,398,650.43. Following the completion of the sale, the insider now owns 65,530 shares of the company’s stock, valued at $3,336,132.30. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider Tomas Brannemo sold 8,524 shares of the firm’s stock in a transaction on Wednesday, August 17th. The shares were sold at an average price of $50.06, for a total value of $426,711.44. The disclosure for this sale can be found here. 0.77% of the stock is currently owned by corporate insiders.
Xylem Company Profile
Xylem Inc is engaged in the design, manufacturing, and application of engineered technologies for the water industry. The Company is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL).
Receive News & Ratings for Xylem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem Inc. and related companies with MarketBeat.com's FREE daily email newsletter.